LMAT vs MDT
LMAT: LeMaitre Vascular is a medical technology company specializing in the development and manufacturing of innovative devices for peripheral vascular surgery. MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions.
Side-by-side fundamentals
| Metric | LMAT | MDT | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $79.64 | $87.75 | |
| Market cap | $1.8B | $112.2B | |
| P/E as of 2026-10-08 | 28.79 | 23.54 | MDT lower |
| PEG | 0.73 | 2.41 | LMAT lower |
| Net margin | +23.1% | +13.2% | LMAT higher |
| Gross margin FY2025, SEC XBRL | +71.5% | n/a | |
| Operating margin | +27.2% | +17.8% | LMAT higher |
| ROE | +14.7% | +9.7% | LMAT higher |
| ROA | +9.4% | +5.2% | LMAT higher |
| Debt / equity as of 2026-09-03 | 0.40 | 0.57 | LMAT lower |
| Revenue growth (YoY) as of 2026-09-03 | +11.8% | +8.4% | LMAT higher |
| Revenue CAGR (3y) SEC XBRL | +15.6% | +5.2% | LMAT higher |
| Dividend yield as of 2026-09-03 | +1.3% | +3.1% | MDT higher |
| Dividend streak (yrs) SEC XBRL | 15 | 14 | LMAT higher |
| Beta as of 2026-09-03 | 0.63 | 0.36 | |
| 1-year return as of 2026-10-08 close | -9.5% | -10.3% | LMAT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.